The program will highlight numerous hot topics including new devices for trancatheter therapeutics, drug eluting stents, novel molecular therapeutics, vascular molecular biology, restenosis solutions, adjunctive drug therapy, carotid and valvular interventions, heart failure interventions and navigational and guidance percutaneous technologies. Included will be emerging technology sessions, industry-academia discussions, and a review of the regulatory aspects of new devices. Thematic live case demonstrations and clinical overviews on specific topics with an emphasis on future perspectives will be presented by leading international experts.